InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Saturday, 08/29/2020 4:02:35 AM

Saturday, August 29, 2020 4:02:35 AM

Post# of 425644
Vascepa is Not a triglycerides lowering drug:

The results of this trial indicate that icosapent ethyl 4 g/day reduces low attenuation plaque volume compared with placebo at 18 months, as measured by cardiac CTA. In addition, there was a reduction in total plaque volume and other plaque parameters as well. In the setting of a small sample size, there was no difference in triglyceride levels. These results may help explain the cardiovascular benefit noted with icosapent ethyl in the REDUCE-IT trial.



Label change?!

BB


If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News